Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
China Shineway Pharmaceutical Group Limited ( (HK:2877) ) has provided an announcement.
China Shineway Pharmaceutical Group Limited has announced a forthcoming board meeting scheduled for March 28, 2025, in Hong Kong. The meeting will address the approval of the company’s annual results for the year ending December 31, 2024, and the consideration of a dividend declaration. This announcement is significant for stakeholders as it indicates the company’s ongoing financial activities and potential shareholder returns.
More about China Shineway Pharmaceutical Group Limited
China Shineway Pharmaceutical Group Limited operates in the pharmaceutical industry, focusing on the production and distribution of traditional Chinese medicine products. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange.
YTD Price Performance: -8.08%
Average Trading Volume: 1,015,133
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: HK$6.7B
See more data about 2877 stock on TipRanks’ Stock Analysis page.